Roman Tiraspolsky Oppenheimer upgraded private equity giant Blackstone ( BX ) to Outperform from Perform as the stock has recently taken a "drubbing," despite its "outstanding performance," especially in its real estate arm. Blackstone ( BX ) stock rose 1.5% in early trading on Monday. Analyst Chris Kotowski pointed to the alternative asset manager's outstanding track record since 2009, when Oppen...
Roman Tiraspolsky Oppenheimer upgraded private equity giant Blackstone ( BX ) to Outperform from Perform as the stock has recently taken a "drubbing," despite its "outstanding performance," especially in its real estate arm. Blackstone ( BX ) stock rose 1.5% in early trading on Monday. Analyst Chris Kotowski pointed to the alternative asset manager's outstanding track record since 2009, when Oppenheimer started covering the company, particularly its strength in real estate. That sector, in addition to private credit, has fallen out of favor. But Oppenheimer sees those fears as overblown. "A distinctive feature of BX is its real estate business, which until recently was its largest generator of fees," Kotowski said. "This real estate business, in our view, is without peer (with Brookfield a somewhat distant #2) and, in our view, represents significant upside in the coming years." He also noted Blackstone's ( BX ) “capital light” business model, which means it has no direct, controlling ownership of an insurance affiliate nor meaningful large balance sheet investments. As a result, almost all of its earnings are returned to shareholders, Kotowski said. "In short, the current dislocation is giving investors a chance to buy the industry's premier franchise at a very attractive valuation," he wrote. Oppenheimer's Outperform rating on Blackstone ( BX ) contrasts with the SA Quant rating of Sell but aligns with the average SA Analyst rating and average Wall Street rating of Buy. More on Blackstone Blackstone: Asset Management Juggernaut, 3.7% Dividend Yield, Phantom Crisis Blackstone: A Discounted Opportunity Blackstone: Valuation Compression Masks Intact Earnings Power Blackstone Digital Infrastructure Trust files for IPO Blackstone plans $2B IPO for acquisition company to buy data centers - report
narvo vexar TruBridge ( TBRG ) advanced 13% on a report that Inventurus Knowledge is in advanced discussions to acquire the firm for around $600 million. A formal announcement is expected in the coming days, according to an Economic Times report on Monday, which cited people familiar with the matter. IKS is negotiating for $675 million in financing with Citi, Deutsche Bank and JPMorgan to back its...
narvo vexar TruBridge ( TBRG ) advanced 13% on a report that Inventurus Knowledge is in advanced discussions to acquire the firm for around $600 million. A formal announcement is expected in the coming days, according to an Economic Times report on Monday, which cited people familiar with the matter. IKS is negotiating for $675 million in financing with Citi, Deutsche Bank and JPMorgan to back its all-cash offer as well as help refinance the target’s debt, according to the report. IKS is backed by the Jhunjhunwala family. TruBridge has a current market cap of about $300 million. IKS CFO Nithya Balakrishnan didn’t respond to queries from the Economic Times, and neither did TrueBridge. More on TruBridge TruBridge, Inc. (TBRG) Q4 2025 Earnings Call Transcript TruBridge expects modest 2026 revenue growth while anticipating 200 bps adjusted EBITDA margin improvement amid strategic review
Global X Funds - Global X Data Center & Digital Infrastructure ETF (NASDAQ:DTCR) was the subject of a major sale by Centurion Wealth Management LLC, which disclosed in its April 10, 2026, SEC filing that it sold 216,719 shares, an estimated $5.30 million transaction based on the quarterly average price. According to its SEC filing dated April 10, 2026, Centurion Wealth Management LLC sold 216,719 ...
Global X Funds - Global X Data Center & Digital Infrastructure ETF (NASDAQ:DTCR) was the subject of a major sale by Centurion Wealth Management LLC, which disclosed in its April 10, 2026, SEC filing that it sold 216,719 shares, an estimated $5.30 million transaction based on the quarterly average price. According to its SEC filing dated April 10, 2026, Centurion Wealth Management LLC sold 216,719 shares of Global X Funds - Global X Data Center & Digital Infrastructure ETF, with an estimated transaction value of $5.30 million based on the average closing price during the first quarter of 2026. The quarter-end value of the position fell by $4.34 million, reflecting both the share sale and price movements. Centurion's DTCR stake now represents 0.4% of its 13F AUM, following this sale. Continue reading
Ilja Enger-Tsizikov /iStock Editorial via Getty Images Shares of GoPro ( GPRO ) are getting a boost Monday after the company said it will pursue new opportunities within the defense and aerospace sectors. The initiative follows the successful mission of Artemis II, in which GoPro ( GPRO ) cameras were mounted on the Orion spacecraft’s solar array wings and used inside the ship for voyage documenta...
Ilja Enger-Tsizikov /iStock Editorial via Getty Images Shares of GoPro ( GPRO ) are getting a boost Monday after the company said it will pursue new opportunities within the defense and aerospace sectors. The initiative follows the successful mission of Artemis II, in which GoPro ( GPRO ) cameras were mounted on the Orion spacecraft’s solar array wings and used inside the ship for voyage documentation. To identify opportunities that align with GoPro’s ( GPRO ) “evolving mission needs,” GoPro ( GPRO ) has engaged consulting firm Oliver Wyman, founded by former Booz Allen Hamilton ( BAH ) partners. “Defense and aerospace customers are increasingly adopting dual-use, commercially available technologies to move faster and operate with greater cost efficiency," said Timothy Wickham, partner in the aerospace and defense practice at Oliver Wyman. "The opportunity is significant and growing, with the global defense and aerospace imaging, unmanned, and related markets representing billions of dollars of addressable market." More on GoPro GoPro: Stronger Profit Execution Offset By Thin Liquidity And Storage Risks GoPro, Inc. (GPRO) Q4 2025 Earnings Call Transcript Stocks to watch on Tuesday after market: LEVI, ASTL, GPRO GoPro cutting workforce by 23% as part of restructuring Seeking Alpha’s Quant Rating on GoPro
georgeclerk/iStock Unreleased via Getty Images BlackRock ( BLK ) is set to report Q1 results on Tuesday, April 14, before the open, with expectations pointing to steady growth but rising scrutiny around credit markets.Consensus estimates call for EPS of $11.48 (+1.6% Y/Y) on revenue of $6.43B (+21.8% Y/Y). The firm has a strong track record, beating EPS estimates in each of the past four quarters,...
georgeclerk/iStock Unreleased via Getty Images BlackRock ( BLK ) is set to report Q1 results on Tuesday, April 14, before the open, with expectations pointing to steady growth but rising scrutiny around credit markets.Consensus estimates call for EPS of $11.48 (+1.6% Y/Y) on revenue of $6.43B (+21.8% Y/Y). The firm has a strong track record, beating EPS estimates in each of the past four quarters, though revenue beats have been less consistent.However, estimate revisions suggest a more cautious tone heading into the print. Over the past three months, EPS forecasts have seen 2 upward revisions against 9 downward, while revenue estimates have seen 1 upward and 4 downward revisions.The bigger overhang is private credit, where recent stress signals have raised questions about valuation transparency and risk exposure across the industry. As one of the largest alternative asset managers, BlackRock’s ( BLK ) commentary on credit conditions, fundraising trends, and potential markdowns will be closely watched.The issue has already surfaced in recent weeks. BlackRock ( BLK ) curbed withdrawals from one of its largest private credit funds in March after a surge in redemption requests . HPS Corporate Lending Fund, one of BlackRock's largest private credit vehicles, saw shareholders request redemptions equivalent to 9.3% of shares in Q1 2026. The fund said it will fulfill only 5% of shares outstanding (about $620M), marking the first time redemption requests exceeded its cap since inception and highlighting growing liquidity strain. Further underscoring the trend, the Financial Times reported that wealthy investors sought to pull more than $10B from major private credit funds in Q1, forcing investment managers to limit redemptions. Debt funds managed by firms, including BlackRock ( BLK ), reportedly agreed to honor ~70% of the $10.1B in redemption requests they have received.Despite the pressure, CEO Larry Fink has downplayed systemic risk, telling the BBC that private credit do...
Two health-care companies began formally marketing US initial public offerings raising as much as $693 million in aggregate, as listing activity in the once-prolific sector increases. Obesity biotech Kailera Therapeutics Inc. revealed it is seeking to raise as much as $533 million from an IPO to help fund the development of its pipeline of obesity drugs. Separately, Alamar Biosciences Inc. , a mak...
Two health-care companies began formally marketing US initial public offerings raising as much as $693 million in aggregate, as listing activity in the once-prolific sector increases. Obesity biotech Kailera Therapeutics Inc. revealed it is seeking to raise as much as $533 million from an IPO to help fund the development of its pipeline of obesity drugs. Separately, Alamar Biosciences Inc. , a maker of medical devices that detect protein biomarkers to diagnose diseases, plans to raise as much as $159.4 million from an IPO to fund research, expand its manufacturing capacity and its sales functions. US health-care companies, including biotechs and medical device makers, have raised $2.37 billion from IPOs so far in 2026, according to data compiled by Bloomberg. While that’s roughly tracking in line with the $10.9 billion raised from the sector last year, 2025 marked the third straight year of annual increases in volume, the data show. Waltam, Massachusetts-based Kailera plans to market 33.3 million shares at $14 to $16 each, according to a filing Monday with the US Securities and Exchange Commission. At the top of the price range, the company would have a market value of $1.9 billion based on the outstanding shares listed in the filing. Kailera has four GLP-1-based drugs in trials, including a once-weekly injectable drug in Phase 3 trials. The company believes its treatment has the potential for the greatest weight loss compared to all obesity management medications currently in the market or in development, the filing shows. The offering is expected to price after the market closes on Thursday, April 16, according to a presentation . Existing shareholders including Bain Capital Private Equity, Bain Capital Life Sciences and Qatar Investment Authority have indicated an interest in buying as much as $225 million of shares in aggregate at the IPO price. Affiliates of Bain Capital will own about a third of the company after the offering, according to the filing. For the ...